Neotame is bad science brought to you by the Monsanto Company.
…Monsanto also has now sold the NutraSweet Company to someone else, but the approval of neotame came under Monsanto’s ownership, and was most likely a result of Monsanto’s cozy relationship with the FDA. More about that in a minute.
…Many people actually consider the FDA to be a “subsidiary” of the Monsanto Company. It sounds impossible, but when you look at all the Monsanto executives who have gone through the revolving door between private industry and government oversight, a truly disturbing picture emerges of the foxes guarding the henhouse.
The FDA is packed by pro-business, pro-corporation advocates who often have massive conflicts of interest when it comes to protecting the health of the public.
In fact, the revolving door between private industry and government oversight agencies is so well established these days, it has become business as usual to read about scandal, conflicts of interest and blatant pro-industry bias, even when it flies in the face of science or the law.
A few examples include:
- FDA Commissioner Margaret Hamburg, a former dental amalgam company executive, helped subvert a federal judge’s order to label mercury fillings as a hazard to children and pregnant women.
- The FDA’s top medical-device regulator, Daniel Schultz, resigned following internal dissent over decisions that his critics said were too friendly to industry.
- Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research, was accused of a massive conflict of interest stemming from an ethics complaint filed by Amphastar Pharmaceuticals Inc.
- The agency’s list of corruptions and collusions is now a mile long. And each piece of new legislation aimed to improve its function seems to do just the opposite—making the FDA even more dependent upon financial support by Big Pharma.
Some days I want to crumble and fall to my knees, but I’m not done. I will infect as much knowledge as I can.